On April 28, 2026, a clinical trial involving sincalide was listed with a status update. The trial, registered as NCT07553754, is titled "Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis." Its current status is recruiting. No phase information was provided for this study. Sincalide is an approved compound being used in the context of this research. The trial record does not include any results or outcome data at this time. No efficacy or safety findings have been reported as part of this update. This brief reflects only the recruitment status and title as listed in the trial registration. Readers interested in the ongoing progress of this study can refer to the official trial registry for further details. For general background on sincalide, readers can consult the compound overview.
Sincalide Trial Update: Prostate Cancer Bone Metastasis Study Recruiting
See the full sincalide overview
Source: https://clinicaltrials.gov/study/NCT07553754